-
Keytruda Improves Survival in Triple-Negative Breast Cancer
Keytruda Improves Survival in Triple-Negative Breast Cancer September 15, 2024 People diagnosed with early-stage triple-negative breast cancer who received the immunotherapy Keytruda (chemical name: pembrolizumab) along with chemotherapy before and after surgery had better event-free survival — how long they lived without…
-
Experience with Keytruda for early stage Triple Negative Breast Cancer
Hi Since the standard of care for early TNBC has changed and now includes Keytruda (Pembrolizumab) with chemotherapy in the neoadjuvant setting, followed by Keytruda alone for 9 cycles in the adjuvant setting, I was wondering if everyone on the current regimen could share their experiences? How has it affected you? Have…
-
Misdiagnosed as Fibroadenoma
My wife noticed a family large lump (4cm) on her left outer breast on 8th sept. We immediately consulted a general surgeon who said he was absolutely certain that it was a fibroadenoma. He sent us to get an ultrasound, and the radiologist saw two lesions 3cm and 1cm next to each other, and said they're definitely…
-
Response with new treatment?
I was diagnosed in December with TNBC - stage IIB in my right breast. I started ac+ Keytruda on 1/17 and finished my last dose on Tuesday 3/21. I begin taxol, carboplatin & Keytruda for 12 weeks beginning 4/11. The response was small on the original mass. They have now found two more lesions that are actively growing…